Market Place
Sourcing Support
Trevena Submits NDA in China for OLINVYK by Jiangsu Nhwa Pharmaceutical
27 Jan 2022 //
GLOBENEWSWIRE
Trevena Announces Two OLINVYK Abstracts Accepted at ANESTHESIOLOGY 2021
30 Aug 2021 //
GLOBENEWSWIRE
Trevena Announces Wake Forest Baptist Health Joining OLINVYK Study
25 Aug 2021 //
GLOBENEWSWIRE
Trevena, Inc. Announces DEA Scheduling of OLINVYK™ (oliceridine) injection
30 Oct 2020 //
GLOBENEWSWIRE
FDA approves Trevena’s Olinvyk for clinical controlled settings
10 Aug 2020 //
BIOWORLD
Trevena Announces Advancement of Oliceridine Clinical Devep in China by Jiangsu
03 Jun 2020 //
GLOBENEWSWIRE
Tiny Trevena returns to FDA in second bid for controversial opioid painkiller
07 Mar 2020 //
ENDPTS
Trevena Announces FDA Has Set PDUFA Date of August 7, 2020 for Oliceridine
05 Mar 2020 //
BIOSPACE
Trevena crushed as analysts count red flags in FDA’s review of its new pain med
10 Oct 2018 //
ENDPTS
FDA put out its in-house assessment of Trevena’s new pain med
09 Oct 2018 //
ENDPTS
Trevena & Pharmbio Korea Announce License & Commercial Agreement for Oliceridine
27 Apr 2018 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.